135 related articles for article (PubMed ID: 11666621)
1. Specific Sequestering Agents for the Actinides. 29. Stability of the Thorium(IV) Complexes of Desferrioxamine B (DFO) and Three Octadentate Catecholate or Hydroxypyridinonate DFO Derivatives: DFOMTA, DFOCAMC, and DFO-1,2-HOPO. Comparative Stability of the Plutonium(IV) DFOMTA Complex(1).
Whisenhunt DW; Neu MP; Hou Z; Xu J; Hoffman DC; Raymond KN
Inorg Chem; 1996 Jul; 35(14):4128-4136. PubMed ID: 11666621
[TBL] [Abstract][Full Text] [Related]
2. Specific sequestering agents for the actinides. 16. Synthesis and initial biological testing of polydentate oxohydroxypyridinecarboxylate ligands.
White DL; Durbin PW; Jeung N; Raymond KN
J Med Chem; 1988 Jan; 31(1):11-8. PubMed ID: 2826783
[TBL] [Abstract][Full Text] [Related]
3. Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of lanthanide(IV) and actinide(IV) ions.
Deblonde GJ; Sturzbecher-Hoehne M; Abergel RJ
Inorg Chem; 2013 Aug; 52(15):8805-11. PubMed ID: 23855806
[TBL] [Abstract][Full Text] [Related]
4. Specific sequestering agents for the actinides. 21. Synthesis and initial biological testing of octadentate mixed catecholate-hydroxypyridinonate ligands.
Uhlir LC; Durbin PW; Jeung N; Raymond KN
J Med Chem; 1993 Feb; 36(4):504-9. PubMed ID: 8386249
[TBL] [Abstract][Full Text] [Related]
5. Complexation of Pu(IV) with the natural siderophore desferrioxamine B and the redox properties of Pu(IV)(siderophore) complexes.
Boukhalfa H; Reilly SD; Neu MP
Inorg Chem; 2007 Feb; 46(3):1018-26. PubMed ID: 17257046
[TBL] [Abstract][Full Text] [Related]
6. Hydroxypyridinonate complex stability of group (IV) metals and tetravalent f-block elements: the key to the next generation of chelating agents for radiopharmaceuticals.
Sturzbecher-Hoehne M; Choi TA; Abergel RJ
Inorg Chem; 2015 Apr; 54(7):3462-8. PubMed ID: 25799124
[TBL] [Abstract][Full Text] [Related]
7. Specific sequestering agents for the actinides. 28. Synthesis and initial evaluation of multidentate 4-carbamoyl-3-hydroxyl-1-methyl-2(1H)-pyridinone ligands for in vivo plutonium(IV) chelation.
Xu J; Kullgren B; Durbin PW; Raymond KN
J Med Chem; 1995 Jul; 38(14):2606-14. PubMed ID: 7629800
[TBL] [Abstract][Full Text] [Related]
8. Plutonium(IV) sequestration: structural and thermodynamic evaluation of the extraordinarily stable cerium(IV) hydroxypyridinonate complexes.
Xu J; Radkov E; Ziegler M; Raymond KN
Inorg Chem; 2000 Sep; 39(18):4156-64. PubMed ID: 11198875
[TBL] [Abstract][Full Text] [Related]
9. Adsorption of Pb(ll) and Eu(III) by oxide minerals in the presence of natural and synthetic hydroxamate siderophores.
Kraemer SM; Xu J; Raymond KN; Sposito G
Environ Sci Technol; 2002 Mar; 36(6):1287-91. PubMed ID: 11944682
[TBL] [Abstract][Full Text] [Related]
10. Competitive binding of Pu and Am with bone mineral and novel chelating agents.
Guilmette RA; Hakimi R; Durbin PW; Xu J; Raymond KN
Radiat Prot Dosimetry; 2003; 105(1-4):527-34. PubMed ID: 14527022
[TBL] [Abstract][Full Text] [Related]
11. Thorium(IV) complexes of bidentate hydroxypyridinonates.
Xu J; Whisenhunt DW; Veeck AC; Uhlir LC; Raymond KN
Inorg Chem; 2003 Apr; 42(8):2665-74. PubMed ID: 12691574
[TBL] [Abstract][Full Text] [Related]
12. Octadentate catecholamide ligands for Pu(IV) based on linear or preorganized molecular backbones.
Durbin PW; Kullgren B; Jeung N; Xu J; Rodgers SJ; Raymond KN
Hum Exp Toxicol; 1996 Apr; 15(4):352-60. PubMed ID: 8845226
[TBL] [Abstract][Full Text] [Related]
13. Chelation therapy by DFO-HOPO and 3,4,3-LIHOPO for injected Pu-238 and Am-241 in the rat: effect of dosage, time and mode of chelate administration.
Volf V; Burgada R; Raymond KN; Durbin PW
Int J Radiat Biol; 1996 Dec; 70(6):765-72. PubMed ID: 8980674
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Tetrakis(3-Hydroxy-4-Pyridinone) Ligand THPN with Zirconium(IV): Thermodynamic Solution Studies, Bifunctionalization, and in Vivo Assessment of Macromolecular
Buchwalder C; Jaraquemada-Peláez MG; Rousseau J; Merkens H; Rodríguez-Rodríguez C; Orvig C; Bénard F; Schaffer P; Saatchi K; Häfeli UO
Inorg Chem; 2019 Nov; 58(21):14667-14681. PubMed ID: 31633347
[TBL] [Abstract][Full Text] [Related]
15. In situ beam reduction of Pu(IV) and Bk(IV) as a route to trivalent transuranic coordination complexes with hydroxypyridinone chelators.
Carter KP; Wacker JN; Smith KF; Deblonde GJP; Moreau LM; Rees JA; Booth CH; Abergel RJ
J Synchrotron Radiat; 2022 Mar; 29(Pt 2):315-322. PubMed ID: 35254293
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and initial evaluation for in vivo chelation of Pu(IV) of a mixed octadentate spermine-based ligand containing 4-carbamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone and 6-carbamoyl-1-hydroxy-2(1H)-pyridinone.
Xu J; Durbin PW; Kullgren B; Ebbe SN; Uhlir LC; Raymond KN
J Med Chem; 2002 Aug; 45(18):3963-71. PubMed ID: 12190318
[TBL] [Abstract][Full Text] [Related]
17. The solution thermodynamic stability of desferrioxamine B (DFO) with Zr(IV).
Toporivska Y; Gumienna-Kontecka E
J Inorg Biochem; 2019 Sep; 198():110753. PubMed ID: 31229836
[TBL] [Abstract][Full Text] [Related]
18. Assignment of complex species by affinity capillary electrophoresis: The case of Th(IV)-desferrioxamine B.
Sladkov V; Roques J; Meyer M
Electrophoresis; 2020 Nov; 41(21-22):1870-1877. PubMed ID: 32543780
[TBL] [Abstract][Full Text] [Related]
19. Metal Coordination Properties of a Chromophoric Desferrioxamine (DFO) Derivative: Insight on the Coordination Stoichiometry and Thermodynamic Stability of Zr
Savastano M; Boscaro F; Bianchi A
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011419
[TBL] [Abstract][Full Text] [Related]
20. Chelation Behaviors of 3,4,3-LI(1,2-HOPO) with Lanthanides and Actinides Implicated by Molecular Dynamics Simulations.
Wang Q; Liu Z; Song YF; Chai Z; Wang D
Inorg Chem; 2023 Mar; 62(10):4304-4313. PubMed ID: 36847745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
